| Full Name | Heather E Rapp |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 200 Penn St, Reading, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174847677 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | PN276725 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Heather E Rapp, 2416 Hay Creek Rd, Birdsboro, PA 19508-8037 Ph: () - | Heather E Rapp, 200 Penn St, Reading, PA 19602-1000 Ph: (610) 372-7712 |
News Archive
Two new studies support and inform the use of proton radiation therapy to treat patients with hepatocellular carcinoma (HCC), a common but often fatal type of liver cancer for which there are limited treatment options. One study (Sanford et al.) suggests that proton radiation, compared to traditional photon radiation, can extend overall survival with reduced toxicity.
Researchers have discovered that females that have multiple sexual partners can be more fertile than those that are monogamous and, very surprisingly, that this is the result of an "overproduction" of sons. The study - still only published as a provisional article but already one of the most accessed in BCM Evolutionary Biology - helps to explain a puzzle that has been haunting evolutionary biologist for decades: why during a mating season so many females chase multiple sexual partners when one is enough to fertilize all her eggs and to do it is costly and dangerous.
A new study has uncovered low rates of referral for palliative care in US patients with end-stage liver disease, although rates have been slowly increasing over time.
Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.
Among patients with end-stage renal disease undergoing living-related kidney transplants, the use of bone-marrow derived mesenchymal (cells that can differentiate into a variety of cell types) stem cells instead of antibody induction therapy resulted in a lower incidence of acute rejection, decreased risk of opportunistic infection, and better estimated kidney function at 1 year, according to a study in the March 21 issue of JAMA.
› Verified 9 days ago
Lisa M Zimmerman, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 200 Penn St, Reading, PA 19602 Phone: 610-372-7712 | |
Larue Greth, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 640 Walnut St, Suite 303, Reading, PA 19601 Phone: 610-208-8860 Fax: 610-208-8861 | |
Joseph C Scheponik, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 200 Penn St, Reading, PA 19602 Phone: 610-372-7712 | |
Joyce A Kramer, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 200 Penn St, Reading, PA 19602 Phone: 610-372-7712 | |
Phyllis A Stanley, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 200 Penn St, Reading, PA 19602 Phone: 610-372-7712 | |
Jessica Druckemiller, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 200 Penn St, Reading, PA 19602 Phone: 610-372-7712 | |
Rachel Stoudt, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 200 Penn St, Reading, PA 19602 Phone: 610-372-7712 Fax: 610-370-6503 |